Repligen RGEN
NASDAQ RGEN
$165.05 -3.48 (-2.06%)
As of: Sep 9, 2026 · 3:59 PM EDT

Repligen (RGEN) Long-Term Debt Issuances (2016 - 2019)

Repligen's (RGEN) quarterly Long-Term Debt Issuances came in at -$89000.0 in Q4 2019, up 64.82% quarter-over-quarter from -$253000.0 in Q3 2016.

Analysis

Repligen (RGEN) Long-Term Debt Issuances (2016 - 2019) Analysis & Trends

Repligen (RGEN) has reported Long-Term Debt Issuances for 2 consecutive years, with -$89000.0 the latest figure, recorded in Q4 2019.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Thermo Fisher Scientific 226.93 Bn 222.99 Bn 8.34 Bn -
2 Danaher 145.94 Bn 141.60 Bn 3.61 Bn 6.56 Bn
3 Agilent Technologies 42.55 Bn 40.79 Bn 1.04 Bn 600.00 Mn
4 Illumina 32.95 Bn 31.78 Bn 770.00 Mn -
5 Revvity 14.53 Bn 13.51 Bn 416.87 Mn -
6 Bio-Techne 11.31 Bn 11.04 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.34 Bn 8.72 Bn 345.80 Mn -
8 Repligen 9.46 Bn 8.44 Bn 110.04 Mn -
9 Bruker 8.91 Bn 8.73 Bn 416.00 Mn -
10 10x Genomics 8.16 Bn 7.61 Bn 112.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -89,000.00
Sep 30, 2016 -253,000.00